“…4,12,15,17,18,23,29,35,36 Recently, whole-brain CTP became available, which might at least overcome the problem of focal perfusion measurement. 10,25,37,38 The aim of this prospective study was to evaluate the role of whole-brain CTP for the identification of tissue at risk for DCI and, thereby, of patients at risk for developing DIND and/or vasospasm-associated infarction, either 1) early after aSAH, prior to the vasospasm period; 2) during rapidly progressive TCD-confirmed vasospasm with or without symptoms; and/or 3) on Day 7 in patients who were comatose or sedated and could not be neurologically assessed.…”